- Status:
- Awaiting development
- Technology type:
- Medicine
- Decision:
- Prioritised
- Prioritisation programme:
- Medicines evaluation
- Rationale:
Criteria within the 2024 Voluntary Scheme for Pricing, Access and Growth (VPAG) met as a new active substance.
- Process:
- STA Standard
- ID number:
- 12422
Email enquiries
If you have any queries please email Topic.Selection@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 05 June 2026 | Awaiting development. Status change linked to topic prioritisation decision being set to Prioritised |
| 05 June 2026 | Prioritisation board meeting |
For further information on how we select topics for development, please see our page about topic prioritisation